Evidence map›Paper›PMID 40959195›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2025

Evaluation of a Modified Single-Stage Continuous Curvilinear Capsulorhexis Technique Using 18-Gauge Needle Decompression in Intumescent Cataracts.

Trung Kien Hoang, Huynh Phuc Nguyen, Van Nam Phan

Abstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Trung Kien HoangDepartment of Ophthalmology, Saigon Vinh Eye Hospital, Vinh City, Vietnam.
Huynh Phuc NguyenDepartment of Ophthalmology, Saigon Vinh Eye Hospital, Vinh City, Vietnam.ORCID 0009-0000-9307-2932
Van Nam PhanDepartment of Ophthalmology, Hue University of Medicine and Pharmacy, Hue City, Vietnam.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the safety and efficacy of a modified anterior capsulorhexis technique using an 18-gauge needle puncture at the peripheral one-third of the anterior capsule to control intralenticular pressure and achieve single-stage continuous curvilinear capsulorhexis (CCC) in intumescent cataract surgery. Methods: This prospective, cross-sectional descriptive study included patients with intumescent cataracts indicated for surgery at Saigon Vinh Eye Hospital from August 2024 to March 2025. Before CCC, all patients underwent an 18-gauge needle puncture at the peripheral one-third of the anterior capsule near the main incision. Results: A total of 99 eyes from 99 patients were included in the study. The mean axial length was 23.12 ± 0.55 mm, anterior chamber depth 2.62 ± 0.43 mm, and lens thickness 4.91 ± 0.72 mm. In 65 patients (65.7%), the milky liquefied cortex escaped into the anterior chamber after the needle puncture. Single-stage CCC was successfully performed in 98 of 99 cases (98.9%) with a mean capsulorhexis diameter of 5.5 ± 0.3 mm. All surgeries were performed using standard phacoemulsification and in-the-bag IOL implantation (100%). Three months post-operatively, all patients had well-centered IOLs with a best-corrected visual acuity (BCVA) ≥ 4/10. Conclusion: An 18-gauge needle puncture at the peripheral one-third of the anterior capsule offers effective decompression, improves safety, and facilitates CCC in patients with intumescent cataracts. This technique is simple, feasible, and highly applicable in clinical practice.

Indexed as

18-gauge needleArgentinian flag signcapsulorhexisintumescent cataract

Identifiers

PMID40959195
PMCPMC12435520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.